- Home
- EPOW vs RADX Comparison
EPOW vs RADX Comparison
Compare EPOW & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- RADX
- Stock Information
- Founded
- EPOW 2014
- RADX 2021
- Country
- EPOW China
- RADX Australia
- Employees
- EPOW N/A
- RADX N/A
- Industry
- EPOW Business Services
- RADX
- Sector
- EPOW Consumer Discretionary
- RADX
- Exchange
- EPOW Nasdaq
- RADX NYSE
- Market Cap
- EPOW 24.8M
- RADX 32.5M
- IPO Year
- EPOW 2021
- RADX N/A
- Fundamental
- Price
- EPOW $0.90
- RADX $4.64
- Analyst Decision
- EPOW
- RADX Strong Buy
- Analyst Count
- EPOW 0
- RADX 3
- Target Price
- EPOW N/A
- RADX $15.00
- AVG Volume (30 Days)
- EPOW 16.4K
- RADX 17.9K
- Earning Date
- EPOW 08-05-2025
- RADX 02-26-2025
- Dividend Yield
- EPOW N/A
- RADX N/A
- EPS Growth
- EPOW N/A
- RADX N/A
- EPS
- EPOW N/A
- RADX N/A
- Revenue
- EPOW $64,997,741.00
- RADX $204,609.00
- Revenue This Year
- EPOW N/A
- RADX N/A
- Revenue Next Year
- EPOW N/A
- RADX N/A
- P/E Ratio
- EPOW N/A
- RADX N/A
- Revenue Growth
- EPOW 44.28
- RADX N/A
- 52 Week Low
- EPOW $0.55
- RADX $3.50
- 52 Week High
- EPOW $1.36
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- EPOW 46.09
- RADX N/A
- Support Level
- EPOW $0.87
- RADX N/A
- Resistance Level
- EPOW $0.95
- RADX N/A
- Average True Range (ATR)
- EPOW 0.04
- RADX 0.00
- MACD
- EPOW -0.00
- RADX 0.00
- Stochastic Oscillator
- EPOW 19.54
- RADX 0.00
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.